Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus standard care for end-of-life agitation
ACTRN12621001499875Phase 2Recruiting
- Sponsor
- Dr Lana Ferguson
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine, sponsored by Dr Lana Ferguson. Started Dec 2021; status: recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ACTRN12621001499875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001499875.